Page last updated: 2024-08-22

nitroxoline and meropenem

nitroxoline has been researched along with meropenem in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA1
Fuchs, F; Hamprecht, A1
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K1

Other Studies

3 other study(ies) available for nitroxoline and meropenem

ArticleYear
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
    European journal of medicinal chemistry, 2022, Jan-15, Volume: 228

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship

2022
Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline.
    The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10

    Topics: Anti-Infective Agents, Urinary; Carbapenem-Resistant Enterobacteriaceae; Enterobacter cloacae; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Nitroquinolines

2019
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
    The Journal of antimicrobial chemotherapy, 2022, 06-29, Volume: 77, Issue:7

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections

2022